BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33178222)

  • 1. Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference.
    Soni D; Van Haren SD; Idoko OT; Evans JT; Diray-Arce J; Dowling DJ; Levy O
    Front Immunol; 2020; 11():590373. PubMed ID: 33178222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines.
    Borriello F; van Haren SD; Levy O
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward precision adjuvants: optimizing science and safety.
    Nanishi E; Dowling DJ; Levy O
    Curr Opin Pediatr; 2020 Feb; 32(1):125-138. PubMed ID: 31904601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontology-based Precision Vaccinology for Deep Mechanism Understanding and Precision Vaccine Development.
    Xie J; Zi W; Li Z; He Y
    Curr Pharm Des; 2021; 27(7):900-910. PubMed ID: 33238868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations.
    Lee B; Nanishi E; Levy O; Dowling DJ
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized vaccinology: A review.
    Poland GA; Ovsyannikova IG; Kennedy RB
    Vaccine; 2018 Aug; 36(36):5350-5357. PubMed ID: 28774561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
    Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G
    Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.
    De Groot AS; Moise L; Terry F; Gutierrez AH; Hindocha P; Richard G; Hoft DF; Ross TM; Noe AR; Takahashi Y; Kotraiah V; Silk SE; Nielsen CM; Minassian AM; Ashfield R; Ardito M; Draper SJ; Martin WD
    Front Immunol; 2020; 11():442. PubMed ID: 32318055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2
    Chen Y; Shu Y; Zheng H; Sun C; Fu C
    Hum Vaccin Immunother; 2024 Dec; 20(1):2300157. PubMed ID: 38198292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The omics strategy: the use of systems vaccinology to characterize immune responses to childhood immunization.
    O'Connor D
    Expert Rev Vaccines; 2022 Sep; 21(9):1205-1214. PubMed ID: 35786291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.
    Dowling DJ; Barman S; Smith AJ; Borriello F; Chaney D; Brightman SE; Melhem G; Brook B; Menon M; Soni D; Schüller S; Siram K; Nanishi E; Bazin HG; Burkhart DJ; Levy O; Evans JT
    Sci Rep; 2022 Oct; 12(1):16860. PubMed ID: 36258023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants.
    Dowling DJ
    Immunohorizons; 2018 Jul; 2(6):185-197. PubMed ID: 31022686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.
    Cotugno N; Ruggiero A; Santilli V; Manno EC; Rocca S; Zicari S; Amodio D; Colucci M; Rossi P; Levy O; Martinon-Torres F; Pollard AJ; Palma P
    J Immunol Res; 2019; 2019():8732191. PubMed ID: 31183393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Immunization: Rationale, Current State, and Future Prospects.
    Whittaker E; Goldblatt D; McIntyre P; Levy O
    Front Immunol; 2018; 9():532. PubMed ID: 29670610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Human Vaccines Project: Towards a comprehensive understanding of the human immune response to immunization.
    Wooden SL; Koff WC
    Hum Vaccin Immunother; 2018; 14(9):2214-2216. PubMed ID: 29847214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update on vaccine research. Proceedings of the 15th annual conference on vaccine research organized by the National Foundation for Infectious Diseases].
    Aubert M; Beytout J; Callamand P; Cheymol J; Combadière B; Dahlab A; Denis F; Dodet B; Dommergues MA; Gagneur A; Gaillat J; Gavazzi G; Gras-le-Guen C; Haas H; Hau-Rainsard I; Malvy D; de Monléon JV; Picherot G; Pinquier D; Pretet JL; Pulcini C; Rabaud C; Regnier F; Rogeaux O; Savagner C; Soubeyrand B; Valdiguié M; Weil-Olivier C;
    Arch Pediatr; 2013 Apr; 20(4):449-58. PubMed ID: 23394726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADITEC: joining forces for next-generation vaccines.
    Rappuoli R; Medaglini D
    Sci Transl Med; 2012 Apr; 4(128):128cm4. PubMed ID: 22491948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.
    Poland GA; Fleming DM; Treanor JJ; Maraskovsky E; Luke TC; Ball EM; Poland CM
    Vaccine; 2013 Apr; 31 Suppl 1():A1-20. PubMed ID: 23587330
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.